The transformation of TAECs into mesenchymal stem cell (MSC)-like cells drives the c-MET-mediated axis that activates the β-catenin/WNT signaling pathway and induces multidrug-resistance-associated protein 1 (MRP1) expression and temozolomide resistance in GBM [94]. This evidence concerns the gene ABCC1 and glioblastoma.